Rare Blood Groups in ABO, Rh, Kell Systems – Biological and Clinical Significance

1. Anstee DJ. The relationship between blood groups and disease. Blood 2010;115:4635–43.10.1182/blood-2010-01-26185920308598 Search in Google Scholar

2. Groot HE, Villegas Sierra LE, Said MA, et al. Genetically determined ABO blood group and its associations with health and disease. Arteriosclerosis Thrombosis and Vascular Biology 2020;40:830–838.10.1161/ATVBAHA.119.31365831969017 Search in Google Scholar

3. Jenkins PV, O’Donnel JS. ABO blood group determinates plasma levels of von Willebrand factor. Transfusion 2006; 46 (10): 1836-1844.10.1111/j.1537-2995.2006.00975.x17002642 Search in Google Scholar

4. Zhang H, Mooney CJ, Reilly MP. ABO Blood Groups and Cardiovascular Diseases. Int J Vasc Med 2012; 2012:641917.10.1155/2012/641917348550123133757 Search in Google Scholar

5. Wu O, Bayoumi N, Vickers MA, Clark P. ABO (H) blood groups and vascular disease: a systematic review and meta-analysis. J Thromb Hae-most 2008; 6:62–9.10.1111/j.1538-7836.2007.02818.x17973651 Search in Google Scholar

6. Hiltunen LM, Laivuori H, Rautanen A, et al. Blood group AB and factor V Leiden as risk factors for pre-eclampsia: A population-based nested case-control study. Thromb Res 2009;124:167–73.10.1016/j.thromres.2008.11.01219110300 Search in Google Scholar

7. Iodice S, Maisonneuve P, Botteri E, et al. ABO blood group and cancer. Eur J Cancer 2010; 46: 3345–3350.10.1016/j.ejca.2010.08.00920833034 Search in Google Scholar

8. Wang Z, Liu L, Ji J et al. ABO blood group system and gastric cancer: a case-control study and meta-analysis. Int J Mol Sci 2012; 13: 13308–13321.10.3390/ijms131013308349732823202954 Search in Google Scholar

9. Wolpin BM, Chan AT, Hartge P, et al. ABO blood group and the risk of pancreatic cancer. J Natl Cancer Inst 2009; 101: 424–431.10.1093/jnci/djp020265709519276450 Search in Google Scholar

10. Gates MA, Wolpin BM, Cramer DW, et al. ABO blood group and incidence of epithelial ovarian cancer. Int J Cancer 2011;128:482–6.10.1002/ijc.25339294696220309936 Search in Google Scholar

11. Matsushita S, Imamura T, Mizuta T, Hanada M. Acquired B antigen and polyagglutination in a patient with gastric cancer. Jpn J Surg 1983; 13 (6): 540–2.10.1007/BF024695006672386 Search in Google Scholar

12. Voskova D, Valekova L, Fedorova J, et al. Leukemic cells and aberrant phenotypes in acute leukemia patients: a flow cytometry analysis. Neo-plasma 2003; 50: 422-7. Search in Google Scholar

13. Bianco-Miotto T, Hussey DJ, Day TK, O’Keefe DS, Dobrovic A. DNA methylation of the ABO promoter underlies loss of ABO allelic expression in a significant proportion of leukemic patients. PloS one 2009;4 (3):e4788.10.1371/journal.pone.0004788265078019274076 Search in Google Scholar

14. Faruque AS., Mahalanabis D, Hoque SS, Albert MJ. The relationship between ABO blood groups and susceptibility to diarrhea due to Vibrio cholerae 0139. Clinical Infectious Diseases 1994;18 (5):827–8.10.1093/clinids/18.5.8278075282 Search in Google Scholar

15. Rowe JA, Handel IG, Thera MA, et al. Blood group O protects against severe Plasmodium falciparum malaria through the mechanism of reduced rosetting. Proceedings of the National Academy of Sciences of the United States of America 2007;104(44):17471–6.10.1073/pnas.0705390104207728017959777 Search in Google Scholar

16. Zhang Y, Garner R, Salehi S, et al. Association between ABO blood types and coronavirus disease 2019 (COVID-19), genetic associations, and underlying molecular mechanisms: a literature review of 23 studies. Ann Hematol 2021;100 (5):1123-1132.10.1007/s00277-021-04489-w793954333686492 Search in Google Scholar

17. Hosoi E. Biological and clinical aspects of ABO blood group system. The Journal of Medical Investigation 2008; 55 (3-4):174-82.10.2152/jmi.55.17418797129 Search in Google Scholar

18. Wagner FF, Moulds JM, Flegel WA. Genetic mechanisms of Rhesus box variation. Blood 2005;45(3):338–44. Search in Google Scholar

19. Allen FH, Krabbe SM, Corcoran PA. A new phenotype (McLeod) in the Kell blood-group system. Vox Sanguinis 1961; 6 (5): 555–60.10.1111/j.1423-0410.1961.tb03203.x13860532 Search in Google Scholar

20. Daniels G, Poole J, de Silva M, et al. The clinical significance of blood group antibodies. Transfusion Med 2002; 12: 287-295.10.1046/j.1365-3148.2002.00399.x12383334 Search in Google Scholar

21. Klein H, Anstee DJ. Mollison’s Blood Trans-fusion in Clinical Medicine, 11th edn. Oxford: Blackwell Science, 2005.10.1002/9780470986868 Search in Google Scholar

22. Daniels G. and members of the ISBT Working Party on Terminology for Red Cell Surface Antigens. Blood group terminology 2004. Vox Sang 2004; 87: 304-316.10.1111/j.1423-0410.2004.00564.x15585029 Search in Google Scholar

23. Dean L. Blood Groups and Red Cell Antigens. Bethesda (MD): National Center for Biotechnology Information (US); 2005. Chapter 8, The Kell blood group. Available from:https://www.ncbi.nlm.gov/books/NBK2270. Search in Google Scholar

24. Reesnik HW. Donors with a rare phenol (geno) type. Vox Sang 2008; 95: 236-53.10.1111/j.1423-0410.2008.01084.x19121189 Search in Google Scholar

25. Peyrard T. The rare blood groups: a public health challenge. Transfus Clin Biol 2008; 15: 109-19.10.1016/j.tracli.2008.02.00118403227 Search in Google Scholar

26. Thornton NM, Grimsley SP. Clinical significance of antibodies to antigens in the ABO, MNS, P1PK, Rh, Lutheran, Kell, Lewis, Duffy, Kidd, Diego, Yt, and Xg blood group systems. Immunohematology 2019; 35 (3):95-101.10.21307/immunohematology-2020-021 Search in Google Scholar

27. Rh null the Rarest Blood Type on Earth, Has Been Called the “Golden Blood”. Curiosity.com. Archived from the original on 5 December 2019. Retrieved 2019-06-05. Search in Google Scholar

28. Bailey P. “The man with the golden blood”. Mosaic Science. Mosaic. Retrieved 16 January 2019. Search in Google Scholar

29. Quershi A, Salman M, Moiz B. Rh null: a rare blood group phenotype.J Pak Med Assoc. 2010;60 (11):960-961. Search in Google Scholar

30. Gabra GS, Bruce M, Watt A, Mitchell R. Anti-Rh 29 in a primigravida with rhesus null syndrome resulting in haemolytic disease of the newborn. Vox Sang. 1987;53(3):143-6.10.1111/j.1423-0410.1987.tb04938.x3120413 Search in Google Scholar

31. Yu LC, Twu YC, Chang CY, Lin M. “Molecular basis of the Kell-null phenotype: a mutation at the splice site of human KEL gene abolishes the expression of blood group antigens”. The Journal of Biological Chemistry. 2001; 276 (13): 10247–52.10.1074/jbc.M00987920011134029 Search in Google Scholar

32. Lin M, Wang CL, Chen FS, Ho LH. Fatal haemolytic transfusion reaction due to anti-Ku in a Knull patient. Immunohematol. 2003;19:19–21.10.21307/immunohematology-2019-469 Search in Google Scholar

33. Russo DC, Lee S, Reid ME, Redman CM. Point mutations causing the McLeod phenotype. Trans-fusion. 2002; 42 (3): 287–93.10.1046/j.1537-2995.2002.00049.x11961232 Search in Google Scholar

34. Mallick S, Kotasthane DS, Chowdhury PS, Sarkar S: Bombay blood group: is prevalence decreasing with urbanization and the decreasing rate of consanguineous marriage. Asian J Transfus Sci 2015;9:129-132.10.4103/0973-6247.162695456213026420929 Search in Google Scholar

35. Oriol R, Candelier JJ, Mollicone R: Molecular genetics of H. Vox Sang 2000;78(2):105-108. Search in Google Scholar

36. Mourat AE. The establishment of an international panel of blood donors of rare types. Vox Sang 1965; 10: 129-132.10.1111/j.1423-0410.1965.tb04330.x14339220 Search in Google Scholar

37. Anstee D. Rare blood. An ISBT working party report on rare blood donors. Vox Sang 1999; 77:58-62.10.1046/j.1423-0410.1999.7710058.x Search in Google Scholar

38. Nance S, Schanrberg EA, Thronton N, et al. International rare donor panels: a review. Vox sang 2015.10.1111/vox.12357 Search in Google Scholar

39. Makarovska-Bojadzieva T, Blagoevska M, Kolevski P, Kostovska S. Optimal blood gouping and antibody screenining for safe transfusion. Contributions, Sec.Biol.Med. Sci. MASA 2009; 30 (1): 119-128. Search in Google Scholar

40. Mollison PL, Engelfriet CP, Contreras M. Blood transfusion in clinical medicine, 10th ed. 1997; Blackwell Scientific Publications, Oxford. Search in Google Scholar

41. Daniels G, Bromilow I. Essential Guide to Blood Groups, 2nd Edition. 2011, Wiley Blackwel.10.1002/9781444325188 Search in Google Scholar

42. Issit PD, Applied blood group serology, 3rd ed. 1985; p.222; Montgomery Scientific Publications, Miami, Florida, U.S.A. Search in Google Scholar

43. Mitra R, Mishra N, Rath GP. Blood group systems. Indian J Anaesth. 2014;58(5):524-528.10.4103/0019-5049.144645 Search in Google Scholar

44. Kahar MA, Patel RD. Phenotype frequencies of blood group systems (Rh, Kell, Kidd, Duffy, MNS, P, Lewis, and Lutheran) in blood donors of south Gujarat, India. Asian J Transfus Sci. 2014; 8(1): 51–55.10.4103/0973-6247.126693 Search in Google Scholar

45. Reid ME, Lomas-Francis C. The Blood Group Antigen Facts Book. Second ed. 2004, New York: Elsevier Academic Press.10.1016/B978-012586585-2/50029-9 Search in Google Scholar

46. Makroo RN, Bahtia A, Gupta R, Philip J. Prevalence of Rh, Duffy, Kell, Kidd & MNSs blood group antigens in the Indian blood donor population. Indian J Med Res. 2013 Mar; 137(3): 521–526. Search in Google Scholar

47. Makarovska Bojadzieva T, Velkova E, Blagoevska M. The impact of extended typing on red cell alloimmunization in transfused patients. Open Access Maced J med Sci. 2017; 5(2):107-111.10.3889/oamjms.2017.054 Search in Google Scholar

48. Stefanovska V.Alloimunization to blood group antigens. Doctoral Thesis. St Cyril and Methodius University, Medical Faculty, Skopje, 1992. Search in Google Scholar

49. Goldstein J, Siviglia G, Hurst R, Lenny L, Reich L. Group B erythrocytes enzymatically converted to group O survive normally in A, B, and O individuals. Science. 1982;215:168–70.10.1126/science.6274021 Search in Google Scholar

50. Goldstein J. Conversion of ABO blood groups. Transfus Med Rev. 1989;3:206–12.10.1016/S0887-7963(89)70080-8 Search in Google Scholar

51. Liu QP, Sulzenbacher G, Yuan H, Bennett EP, Pietz G, Saunders K, et al. Bacterial glycosidases for the production of universal red blood cells. Nat Biotechnol. 2007;25:454–64.10.1038/nbt129817401360 Search in Google Scholar

52. Kobayashi T, Liu D, Ogawa H, Miwa Y, Nagasaka T, Maruyama S, et al. Alternative strategy for overcoming ABO incompatibility. Transplantation. 2007;83:1284–6.10.1097/01.tp.0000260634.85690.c417496551 Search in Google Scholar

53. Nacharaju P, Boctor FN, Manjula BN, Acharya SA. Surface decoration of red blood cells with maleimidophenyl-polyethylene glycol facilitated by thiolation with iminothiolane: an approach to mask A, B, and D antigens to generate universal red blood cells. Transfusion. 2005 Mar;45(3):374-83.10.1111/j.1537-2995.2005.04290.x15752155 Search in Google Scholar

54. Hashemi-Najafabadi S, Vasheghani-Farahani E, Shojaosadati SA, Rasaee MJ, Armstrong JK, Moin M, et al. A method to optimize PEG-coating of red blood cells. Bioconjug Chem. 2006;17:1288–93.10.1021/bc060057w16984140 Search in Google Scholar

55. Yoojin S, Kyung-Hwa S, Hyung HK, Hyung-Sik K. Current Advances in Red Blood Cell Generation Using Stem Cells from Diverse Sources. Stem Cells International, vol. 2019. https://doi.org/10.1155/2019/9281329.670131631467565 Search in Google Scholar

56. Tarafdar S, Mondy P, Powley T, et al. Understanding the demand for phenotyped red blood cell units and requests to perform molecular red blood cell typing for Australian patients. Transfusion and Apheresis Science 2020; 60(1):102968. Search in Google Scholar

57. Liu Z, Zeng R, Chen Q, et al. Genotyping for Kidd, Kell, Duffy, Scianna, and RHCE blood group antigens polymorphisms in Jiangsu Chinese Han Chin Med J 2012;125(6):1076-81.. Search in Google Scholar